Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals Ownership Summary

Anebulo Pharmaceuticals is owned by 1.07% institutional investors, 40.84% insiders, and 58.10% retail investors. 22nw, lp is the largest institutional shareholder, holding 37.65% of ANEB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.61% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anebulo Pharmaceuticals	1.07%	40.84%	58.10%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
22nw, lp	15.47M	37.65%	$84.76M
Mangrove partners	2.53M	7.47%	$6.31M
Nantahala capital management	3.04M	7.39%	$3.07M
Vanguard group	435.82K	1.06%	$440.18K
Morgan stanley	399.40K	0.97%	$403.40K
Ikarian capital	157.72K	0.47%	$394.30K
Geode capital management	160.76K	0.39%	$162.48K
Northern trust	24.39K	0.07%	$60.98K
Renaissance	25.10K	0.06%	$25.35K
Rangeley capital	20.00K	0.06%	$50.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
22nw, lp	15.47M	35.68%	$84.76M
Mangrove partners	2.53M	0.47%	$6.31M
Nantahala capital management	3.04M	0.10%	$3.07M
Rangeley capital	20.00K	0.04%	$50.00K
Ikarian capital	157.72K	0.04%	$394.30K
Xtx topco	19.15K	0.00%	$47.88K
Boothbay fund management	18.84K	0.00%	$47.09K
Tower research capital llc (trc)	1.75K	0.00%	$4.38K
Susquehanna group, llp	-	-	-
Barclays	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	435.82K	-	129.28K
Northern trust	24.39K	-	24.39K
Rangeley capital	20.00K	0.04%	20.00K
Xtx topco	19.15K	0.00%	19.15K
State street	12.77K	-	12.77K

Top Sellers

Holder	Shares	% Assets	Change
Lvw advisors	-	-	-349.62K
King luther capital management	-	-	-59.66K
Susquehanna group, llp	-	-	-25.25K
Hrt financial lp	-	-	-23.16K
Geode capital management	160.76K	-	-13.35K

New Positions

Holder	Shares	% Assets	Change	Value
Northern trust	24.39K	-	24.39K	$60.98K
Rangeley capital	20.00K	0.04%	20.00K	$50.00K
Xtx topco	19.15K	0.00%	19.15K	$47.88K
State street	12.77K	-	12.77K	$31.92K

Sold Out

Holder	Change
Citigroup	-6.00
Ameritas advisory services	-10.00
Wells fargo & company/mn	-62.00
Barclays	-399.00
Pnc financial services group	-1.53K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	2	-90.00%	438,155	-98.03%	1	0.02%	2	-83.33%	-	-100.00%
Sep 30, 2025	3	-80.00%	308,684	-98.61%	-	0.01%	3	-57.14%	-	-100.00%
Jun 30, 2025	18	-	22,591,946	-0.12%	82	2.72%	8	-11.11%	3	-25.00%
Mar 31, 2025	18	20.00%	22,618,242	0.21%	55	0.73%	9	12.50%	4	-
Dec 31, 2024	15	15.38%	22,570,347	207.34%	87	10.85%	8	60.00%	4	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	248.95K	0.61%	-8.96K
Vanguard US Total Market Shares ETF	121.00K	0.29%	-
Vanguard Institutional Extnd Mkt Idx Tr	116.25K	0.28%	-4.18K
Fidelity Extended Market Index	49.40K	0.12%	-95.00
Fidelity Total Market Index	47.66K	0.12%	-
Fidelity Series Total Market Index	21.36K	0.05%	-
Spartan Total Market Index Pool G	20.11K	0.05%	-
iShares Micro-Cap ETF	20.17K	0.05%	-
NT Ext Equity Mkt Idx Fd - NL	15.06K	0.04%	15.06K
Spartan Extended Market Index Pool F	14.13K	0.03%	95.00

Recent Insider Transactions

Date	Name	Activity	Value
Dec 23, 2024	English Aron R.	Buy	$10.00M
Dec 17, 2021	English Aron R.	Buy	$2.63K
Dec 14, 2021	English Aron R.	Buy	$2.43K
Dec 03, 2021	English Aron R.	Buy	$26.68K
Dec 02, 2021	English Aron R.	Buy	$73.33K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-

ANEB Ownership FAQ

Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 1.07%, followed by 40.84% insiders and 58.09% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are 22nw, lp (15.47M shares, 37.65%), Mangrove partners (2.53M shares, 7.47%), and Nantahala capital management (3.04M shares, 7.39%). Together, they hold 52.50% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Anebulo Pharmaceuticals.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 35.68% of its assets in 15.47M Anebulo Pharmaceuticals shares, valued at 84.76M$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.61% of its total shares outstanding invested in 248.95K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools